	US 12,448,614 B2
	Enzymes for glycan analysis
Fredrik Leo, Lund (SE); Rolf Lood-Alayón, Lund (SE); Stephan Bjork, Lund (SE); Malin Mejare, Lund (SE); and Fredrik Olsson, Lund (SE)
Assigned to Genovis AB, Lund (SE)
Appl. No. 16/616,872
Filed by Genovis AB, Lund (SE)
PCT Filed May 25, 2018, PCT No. PCT/EP2018/063833 § 371(c)(1), (2) Date Nov. 25, 2019, PCT Pub. No. WO2018/215657, PCT Pub. Date Nov. 29, 2018.
Claims priority of application No. 1708471 (GB), filed on May 26, 2017; application No. 1708476 (GB), filed on May 26, 2017; and application No. 1806655 (GB), filed on Apr. 24, 2018.
Prior Publication US 2020/0087643 A1, Mar. 19, 2020
Int. Cl. C12N 9/24 (2006.01); C12N 9/52 (2006.01); G01N 33/68 (2006.01); G01N 33/84 (2006.01)

CPC C12N 9/2402 (2013.01) [C12N 9/52 (2013.01); G01N 33/68 (2013.01); G01N 33/84 (2013.01); C12Y 304/24057 (2013.01); G01N 2333/924 (2013.01); G01N 2333/952 (2013.01)]

9 Claims

1. A composition or combination comprising a first sialidase, a second sialidase, and an O-glycosidase, wherein: the first sialidase is a polypeptide comprising or consisting of the amino acid sequence of SEQ ID NO: 2; the second sialidase is a polypeptide comprising or consisting of the amino acid sequence of SEQ ID NO: 5; and the O-glycosidase is a polypeptide comprising or consisting of the amino acid sequence of SEQ ID NO: 10.